PERİODONTİTİS KARDİYOVASKÜLER HASTALIĞA NEDEN OLUR MU?

1. Haake SK, Nisengard RJ, Newman MG, Miyasaki KT. Microbial interactions with the host in periodon-tal disease. In: Clinical Periodontology Ed: Newman MG, Takei HH, Carranza FA.9th Ed. W.B Saunders Company. 2002:132-153
2. Mealey BL, Klokkevold PR. Periodontal medicine. In: Clinical Periodontology Ed: Newman MG, Takei HH, Carranza FA.9th Ed. W.B Saunders Company.
2002: 229-245
3. Debelian GJ, Olsen I, Tronstad L. Systemic diseases caused by oral microorganisms. Endod Dent Traumatol 1994;10(2):57-65
4. Drangsholt MT. A new causal model of dental dis¬eases associated with endocarditis. Ann Periodontol. 1998 Jul;3(1):184-96
5. Page RC. The pathobiology of periodontal diseases may affect systemic diseases: Inversion of a para¬digm. Ann Periodontol.1998; 3(1): 108-120
6. Türk kalp vakfı bildirisi. 2002
7. Griffin BP. Valvular heart disease. In: Dale DC, Federman DD, editors. Scientific American Medi¬cine. New York, NY: Scientific American Inc. 1999
8. Karchmer AW. Infective endocarditis. In:Dale DC, Federman DD, editors. Scientific
American Medicine. New York, NY: Scientific American Inc. 1999
9. Cowper TR. Pharmocologic management of the patient with disorders of the cardiovascular system. Infective endocarditis. Dent Clin North Am1996 ; 40:611-47
10.Daly C, Mitchell D, Grossberg D. Bacteremia caused by periodontal probing. Aust Dent. J 1996;
42:77-80
11.Dajani AS, Taubert KA, WilsonW. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997 ;
277:1794-1801
12.Strom BL, Abrutyn E, Berlin JA. Dental and car¬diac risk factors for infective endocarditis. A popula¬tion based, case-control study. Ann Intern Med
1998,129:761-769
13. Fay JT, O'Neal RB. Dental responsibility for the medically compromised patient IV. J Oral Med 1984;
39:218-225
14. Klimartin C, Munroe C. The dental management of the cardiac patient requiring antibiotic prophylaxis. J
Can Dent Assoc1986; 52:77-82
15. Klimartin C, Munroe C. Cardiovascular diseases and the dental patient. J Can Dent Assoc 1986;
52:513-518
16. Lowe GDO: Etiopathogenesis of cardiovascular disease: Hemostasis, thrombosis, and vascular medi¬cine. Ann Periodontal 1998;3:121
17. Ross R. Atherosclerosis- an inflammatory disease.
N Engl J Med 1999;340:115-126
68
Atatürk Üniv. Diş Hek. Fak.
Cilt: 15, Sayı:2, Sayfa:62-70, 2005
ÖZER, DEMİRALP
18. Grayston JT, Kuo C-C, Coulson AS. Chlamydia
pneumaniae (TWAR) in atherosiclerosis of the carotid artery. Circulation 1995;92:3397-3400
19. Ebersole JL., Cappelli D. Acute phase reactants in infections and inflammatory diseases. Periodontol
2000 2000; Jun (23): 19-49 20.Poston RN, Haskard Do, Coucher JR, Gall NP, Jhonson-Tidey RR. Expression of adhesion molecule 1 in atherosclerotic plaques. Am J Pathol
1992;140:665-673
21. Davies MJ, Gordon JL, Gaering AHJ. The expres¬sion of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin human atherosclerosis. J
Pathol 1993; 171 :223-229
22. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leuko¬cyte count with coronary heart disease. Meta-analy-ses of prospective studies. JAMA 1998; 279:1477¬1482
23. Danesh J, WhincupP, Walker M. Low grade inflam¬mation and coronary heart disease: Prospective study and updated meta-analyses. Br Med 2000; 321:199¬204
24. ECAT Anjina Pectoris Study Group. ECAT anjina pectoris study: Baseline associations of hemostatic factors with extent of coronary arteriosclerosis and oyher coronary risk factors in 3000 patients with anjina pectoris undergoing coronary angiography.
Eur Heart J 1993;14:8-14
25. Lowe GDO. Fibrinogen - a cardiovascular risk fac¬tor. Mannheim:Boehringer Mannheim, 1997.
26. Woodward M, Lowe GDO, Rumley A, Tunstall-Pedoe H. Fibrinogen as a risk factor for coronary heart disease and mortality in middle aged men and women. The Scotthish Heart Health Study. Eur Heart J 1998; 19:55-62
27. Mattila KJ, Valtonen VV, Nieminen M, Hattunen JK. Dental infection and the risk of new coronary events: Prospective study of patients with document¬ed coronary artery disease. Clin Infect Dis 1995;
20:588-592
28. DeStefano, F., Anda, R.F., Kahn, H. S., Williamson D.F. & Russel. C. M. Dental disease and risk of coro¬nary heart disease and mortality. British Medical
Journal 1993; 306:688-691
29. Joshipura, K.J., Rimm, E. B., Douglass, C. W., Tricopoulos, D., Ascherio, A.& Willet. W. C. Poor oral health and coronary heart disease. Journal of Dental Research 1996; 75: 1631-1636
30. Morrison, H. I., Ellison, L.F.& Taylor G.W.
Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. Journal of
Cardiovascular Risk 1999; 66:572-578
31. Hujoel, P., P., Drangsholt, M., Spiekerman. C. & DeRoven, T. A. Periodontal disease and coronary heart disease risk. Journal of Am Med Association
2000; 284:1406-1420
32. Emingil G., Buduneli E., Aliyev A., Akilli A.& Atilla G. Association between periodontal disease and acute myocardial infarction. J Periodontol 2000;
71:1882-1886
33.Malthaner S. C., Moore S., Mills M., Saad R., Sabatini R., Takacs V., McMahan C. A., Oates W. T.
Investigation of the association between angiograph-ically defined coronary artery disease and periodon-
tal disease. J Periodontol 2002;73:1169-1176
34. Wu T., Trevisan, M., Genco, R. J., Falkner, K. L., Dorn, J. P. & Sempos, C. T. Examination of the rela¬tion between periodontal health status and cardio¬vascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein and plas¬ma fibrinogen. American Journal of Epidemiology
2000;151:273-282
35. Chiu B. Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999; 138:534-536
36. Haraszthy VI, Zambon JJ, Trevisan M., Zeid M., Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000; 71:1554¬1560
37. Dorn BR, Dunn WA Jr., Progulske-Fox A. Invasion of aortic and human coronary artery cells by peri-odontal pathogens. Infect Immun 1999; 67:5792¬5343
38. Chung HJ, Riche EL, Levy RS. Establishment of a mouse model of infection-induced atheroma forma¬tion. J Dent Res 2000;79(Spec. Issue):313(Abstr.
1356)
39. Herzberg, M. Platelets and bacterial infections. In: Gresele P, Page CP, Fuster V, Vermylen , eds. Platelets in thrombotic and non-thrombotic disor¬ders. Cambridge: Cambridge University Press, 2001
69
Atatürk Üniv. Diş Hek. Fak.
Cilt: 15, Sayı:2, Sayfa:62-70, 2005
ÖZER, DEMİRALP
40. Ebersole JL, Machen RL, Steffen ML, Willmann
DE. Systemic acute phase reactants, C-reactive pro¬tein and haptoglobin, in adult periodontitis. Clin Exp
Immunol 1997; 107;347-352
41. Xu
Q
, Wick G. The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol Med Today 1996; 2 (9); 372-379
42. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265;621-
636
43. Yudkin YS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healty subjects: Associations with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue?
Arterioscler Thromb Vasc Biol 1999; 19;972-978
44.Kornmann Kenneth S, Newman Micheal G. Role of genetics in assessment, risk, and management of adult periodontitis. Periodontal Medicine, 2000; 45¬62
45.Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol 1996;1;821-866
46. Preiss DS, Meyle J. Interleukin-1 concentration of gingival crevicular fluid. J Periodontol1994; 65;423-
428
47. Kornmann KS, Crane A, Wang H-Y. The inter-leukin-1 genotype as a severity factor in adult peri-odontal disease. J Clin Periodontol 1997;24;72-77
48. Francis SE, Camp NJ, Dewberry RM. Interleukin-1 receptor antagonist gene polymorphism and coro¬nary artery disease. Circulation 1999;99;861-866
49. Cox A, Camp NJ, Cannings C. Combined sib-TDT and TDT provide evidence for linkage of the inter-leukin 1 gene cluster to erosive rheumatoid arthritis.
Hum Mol Genet 1999;8; 1707-1713
50. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91;2844-2850
51. Henney AM, Ye S, Zhang B. Genetic diversity in the matrix metalloproteinase family. Effects on func¬tion and disese progression. Ann NYAcad Sci 2000;
902:27-37
52. Ryan ME, Golub LM . Modulation of matrix metal-loproteinase activities in periodontitis as a treatment
strategy. Periodontol 2000 2000; 24:226-238
53. Baldwin AS Jr. Series introduction: The transcrip¬tion factor NF-?B and human disease. J Clin Invest
2001;107:3-6
54. Romashkova JA, Makarov SS. NF-kappaB is a tar¬get of AKT in anti-apoptatic PDGF signaling. Nature 1999;Sep 2;401:86-90
55. Beck J, Garcia J, Heiss G. et al. Periodontal disease and cardiovascular disease. J Periodontol
1996;67:1123-1137
56. Position paper. Tobacco use and the periodontal patient. J Periodontol 1999;70: 1419-1427
57. Tomar SL, Asma S. Smoking attributable periodon-titis in the United States: findings from NHANES
III. J Periodontol 2000;71: 743-750
58. Papapanou PN. Risk assessments in the diagnosis and the treatment of periodontal diseases. J Dent
Educ 1998; 62: 822-829
59. Jee SH, Suh I, Kim IS, Appel Lj. Smoking and ath¬erosclerotic cardiovascular disease in men with low levels of serum cholesterol. JAMA 1999;282;231-
242
60. Hubert HB, Holford TR, Kannel WB. Clinical char¬acteristics and cigarette smoking in reletion to prog¬nosis of anjina pectoris in Framingham. Am J
Epidermol 1982;115:231-242
61. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking under 55 years of age. N Engl J Med
1985;13:1511-1515
62. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who
stopped smoking. N Engl J Med 1990;322:213-217
63. Hujoel PP. Does chronic periodontitis cause coro¬nary heart disease? A review of the literature. JADA 2002;133:Suppl:31S-36S